FET-PET-Guided Management of Pseudoprogression in Glioblastoma
FET-PET-Guided Management of Pseudoprogression in Glioblastoma
Not yet recruiting · NCT06480721 · Registry updated 2024-06-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FET-PET-Guided Management of Pseudoprogression in Glioblastoma | Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not applicable | 2024-06-28 | NCT06480721 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Curium PET France | 1 |
| Veerle Ruijters | 1 |
| ZonMw: The Netherlands Organisation for Health Research and Development | 103 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC | Amsterdam | Netherlands | 85 |
| Erasmus MC | Rotterdam | Netherlands | 57 |
| Haaglanden MC | The Hague | Netherlands | 6 |
| Maastricht UMC | Maastricht | Netherlands | 23 |
| Medisch Spectrum Twente | Enschede | Netherlands | 36 |
| Radboud UMC | Nijmegen | Netherlands | 25 |
| UMC Groningen | Groningen | Netherlands | 17 |
| UMC Utrecht | Utrecht | Netherlands | 6 |